{"filings":[{"id":609476,"accession_number":"0001822479-26-000034","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2026-05-22T20:09:28+00:00","items":["5.07"],"status":"ready","headline":"Sotera Health stockholders elect all four director nominees, approve say-on-pay, ratify auditor at 2026 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Directors Sean Cunningham, Richard Kyle, Vincent Petrella, Christopher Simon elected as Class III directors for three-year term.","Say-on-pay advisory resolution passed with 257.7M votes for, 6.6M against.","Ernst & Young LLP ratified as independent auditor for FY2026 with 267.3M votes for.","All proposals passed without broker non-votes impacting director elections or advisory vote."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":554520,"accession_number":"0001193125-26-232585","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2026-05-20T20:10:41+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Sotera Health reprices $1.42B term loans, reduces spread by 25 bps to SOFR+2.25%","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment No. 7 refinances $1,415,914,726 of term loans; interest spread cut 0.25% to Adjusted Term SOFR + 2.25%.","New term loans amortize at 1.00% per annum and mature on May 30, 2031.","Soft call premium of 1.00% applies to repricing transactions within six months of effective date.","Proceeds plus cash on hand used to repay all existing term loans in full.","Transaction closed May 20, 2026; no event of default occurred."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":68242,"accession_number":"0001193125-26-221630","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2026-05-13T20:11:15+00:00","items":["1.02","8.01","9.01"],"status":"ready","headline":"Sponsors Warburg Pincus and GTCR exit Sotera Health via secondary offering; Stockholders Agreement terminated.","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Selling stockholders (Warburg Pincus & GTCR affiliates) sold 31,838,253 shares at $15.168 per share.","Company received no proceeds; all shares were sold by sponsors, reducing their ownership to zero.","Stockholders Agreement terminated, ending sponsors' special governance rights including director designation.","Existing sponsor-designated directors may continue serving until their terms expire; no immediate board changes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95835,"accession_number":"0001822479-26-000028","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Sotera Health reports Q1 2026 results and announces CEO transition","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 net revenues up 10.0% (6.5% constant currency); net income $27M vs loss $13M in prior year.","Adjusted EBITDA increased 10.5% (6.9% constant currency); Adjusted EPS $0.18, up 29%.","Michael Petras appointed Executive Chairman; Alton Shader named CEO effective May 26, 2026.","Reaffirmed 2026 outlook: net revenue growth 5.0%-6.5% and Adj. EBITDA growth 5.5%-7.0% constant currency.","Added independent directors Rich Kyle and Ken Krause to Board; public float ~90%."],"consensus_eps_estimate":0.1763,"consensus_eps_actual":0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":280045000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109170,"accession_number":"0001822479-26-000019","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2026-03-16T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Constantine S. Mihas resigns; Kenneth D. Krause appointed to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Constantine S. Mihas resigns as Class I director effective March 16, 2026, due to reduction in board seats certain stockholders can designate. No disagreement.","Kenneth D. Krause, EVP and CFO of Rollins, Inc., appointed as Class I director effective March 16, 2026.","Krause will serve on Audit and Litigation Committees and is deemed independent under Nasdaq rules.","Krause will receive standard non-employee director compensation: annual cash retainer and restricted stock units.","No arrangement or understanding for appointment; no reportable transactions between Krause and Sotera."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109169,"accession_number":"0001193125-26-096983","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2026-03-06T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Sotera Health selling stockholders launch 25M-share secondary offering at $15.27 each","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Selling stockholders sold 25 million shares at $15.27 per share; company receives no proceeds.","None of Sotera's executive officers participated in the offering; no dilution to existing shareholders.","Underwriter is Wells Fargo Securities; offering closed on March 6, 2026.","Total offering value approximately $382 million based on the offering price."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109168,"accession_number":"0001822479-26-000012","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Sotera Health reports 2025 record revenue up 5.7% to $1.164B; guided 2026 growth 5-6.5%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["2025 net revenue $1.164B (+5.7% YoY), net income $78M ($0.27 EPS) vs $44M ($0.16).","Adjusted EBITDA $594M (+8.2% YoY), Adjusted EPS $0.86 (+$0.16).","Q4 2025 revenue $303M (+4.6% YoY), net income $35M ($0.12) vs $12M ($0.04).","2026 outlook: revenue growth 5.0-6.5%, Adj EBITDA growth 5.5-7.0% on constant currency.","GC Alex Dimitrief to retire Mar 31, 2026; succeeded by Erika Ostrowski; advisory fee $22,500/mo."],"consensus_eps_estimate":0.2449,"consensus_eps_actual":0.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":1163617000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109167,"accession_number":"0001822479-26-000007","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2026-02-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Sotera Health appoints Richard G. Kyle to Board of Directors as Class III director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board size increased from 11 to 12; Kyle appointed Class III director effective Feb 4, 2026.","Kyle served as President and CEO of The Timken Company from May 2014 to September 2024.","He will serve on the Leadership Development and Compensation Committee and Nominating and Corporate Governance Committee.","Kyle is independent per Nasdaq rules and will receive standard non-employee director compensation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109166,"accession_number":"0001822479-26-000004","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Sotera Health expects FY2025 revenue >$1.16B, up at least 5.5% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue expected to exceed $1.16 billion for full-year 2025, a YoY increase of at least 5.5% (5.0% constant-currency).","Company reports over two decades of consecutive annual revenue growth.","Full-year results and 2026 outlook to be released on February 24, 2026.","Management presenting at 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026."],"consensus_eps_estimate":0.2449,"consensus_eps_actual":0.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":1163617000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125667,"accession_number":"0001193125-25-274199","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2025-11-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Sotera Health selling stockholders to sell 30M shares at $15.651 each","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Underwriting agreement signed Nov 6, 2025 for 30M shares at $15.651/share via Goldman Sachs.","Selling stockholders, not the company, sold shares; Sotera Health receives no proceeds.","Sale completed on Nov 10, 2025; company did not issue any new shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125666,"accession_number":"0001822479-25-000050","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sotera Health Q3 net revenues +9.1% to $311M; adj EBITDA +12.2%; raises 2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net revenues rose 9.1% to $311M; net income $48M ($0.17 diluted EPS) vs $17M ($0.06) a year ago.","Adjusted EBITDA up 12.2% to $164M; Adjusted EPS $0.26 (+$0.09 YoY); constant-currency rev growth 8.0%.","Nine-month 2025 net revenues $860M (+6.2%); net income $43M includes $34M pending EO settlement charge.","2025 guidance: reaffirms constant-currency revenue growth 4.5%-6.0%; raises adj EBITDA growth to 6.75%-7.75%.","Sterigenics volumes strong; Nordion double-digit growth; Nelson Labs margin expansion."],"consensus_eps_estimate":0.2208,"consensus_eps_actual":0.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":860176000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142394,"accession_number":"0001193125-25-207549","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2025-09-18T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Sotera Health refinances $1.423B term loans, cuts interest margin by 0.50%","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment No. 6 reduces term loan interest spread by 0.50% to SOFR + 2.50% (0.00% floor).","Applied $75M cash to repay existing borrowings; new term loan principal is $1,423,029,875.","Repriced term loans amortize at 1.00% per annum and mature May 30, 2031.","Soft call premium of 1.00% applies for certain repricing transactions within six months.","Proceeds from new loans and cash on hand fully refinanced existing term loans."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142393,"accession_number":"0001193125-25-197231","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2025-09-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Sotera Health selling stockholders sell 20M shares in secondary offering at $15.111/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Selling stockholders sold 20,000,000 shares of common stock at $15.111 per share.","Goldman Sachs & Co. LLC acted as sole underwriter for the offering.","Company did not sell any shares and will not receive any proceeds from the sale.","Underwriting agreement signed September 3, 2025; sale closed September 5, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142392,"accession_number":"0001822479-25-000041","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2025-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sotera Health Q2 revenue up 6.4% to $294M; Adj EBITDA +9.8% to $151M; raises FY outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net revenues $294M (+6.4% YoY); constant currency +6.0%; net income $8M ($0.03 diluted EPS).","Adjusted EBITDA $151M (+9.8% YoY); Adjusted EPS $0.20 vs $0.19 prior year.","Company raises full-year 2025 outlook: net revenue growth 4.5%-6.0%, Adj EBITDA growth 6.0%-7.5% constant currency.","Net income impacted by $34M pending settlement related to ethylene oxide claims against Sterigenics.","First-half 2025 net revenues $549M (+4.6% YoY); net loss $5M due to settlements totaling $65M."],"consensus_eps_estimate":0.1746,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":548864000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142391,"accession_number":"0001822479-25-000036","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2025-07-24T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Sotera Health subsidiary Sterigenics settles 129 EO claims for $34M","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Sterigenics enters binding term sheet to resolve 129 ethylene oxide (EO) claims for $34,000,000.","Settlement includes 10 claims set for trial in Oct 2025 and Mar 2026; process expected 60–90 days.","Settlement conditioned on 100% claimant participation, stays of trials, and court good-faith determination; Sterigenics can waive participation requirement.","Sterigenics denies any liability; term sheet explicitly states no admission of hazard from Willowbrook facility.","The settlement dismisses claims with prejudice and covers 56 pending lawsuits and 63 unfiled claims."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160428,"accession_number":"0001822479-25-000028","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2025-05-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Sotera Health stockholders elect directors, approve pay, ratify auditor at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected Ruoxi Chen, Karen A. Flynn, and Ann R. Klee as Class II directors for three-year terms.","Advisory approval of named executive officer compensation passed with 272,812,479 votes for, 1,865,802 against.","Ratification of Ernst & Young LLP as independent auditor for FY 2025 approved: 275,831,763 for, 1,851 against.","Broker non-votes were 911,848 on director elections and say-on-pay; no broker non-votes on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160427,"accession_number":"0001822479-25-000022","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sotera Health Q1 net loss $13M includes $31M EO settlement; Adj EBITDA up 8.8%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues $255M, up 2.6% YoY (4.4% constant currency). Sterigenics segment $170M.","Net loss $13M ($0.05 diluted loss) vs net income $6M ($0.02) in Q1 2024; includes $31M EO settlement charge.","Adjusted EBITDA $122M, up 8.8% (11.2% constant currency). Adjusted EPS $0.14 vs $0.13.","Company reaffirms FY2025 constant-currency outlook: 4-6% net revenue growth, 4.5-6.5% Adj EBITDA growth."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":254523000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160426,"accession_number":"0001822479-25-000018","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2025-04-04T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Sotera Health's Sterigenics settles 97 EO claims for $30.9M","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Settlement covers 97 ethylene oxide claims related to former Willowbrook, IL facility.","Sterigenics to pay $30,943,000; claims dismissed with prejudice.","Includes 7 trial-set cases for April/June 2025 and 90 other claims by same counsel.","Settlement requires 100% claimant participation and court good-faith determination.","Sterigenics denies any liability; settlement not an admission of hazard."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178690,"accession_number":"0001822479-25-000012","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sotera Health FY2024 revenue up 4.9% to $1.10B; net income down to $44M; provides 2025 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenues down 6.5% to $290M; net income $12M ($0.04 EPS) vs $39M ($0.14 EPS) in Q4 2023.","Full-year net revenues $1.10B (+4.9%); net income $44M ($0.16 EPS) vs $51M ($0.18 EPS) in 2023.","Adjusted EBITDA $549M (+3.9% YoY); Adjusted EPS $0.70 (down $0.02 YoY).","2025 guidance: net revenue growth 4.0%-6.0%, Adjusted EBITDA growth 4.5%-6.5% constant currency.","CEO highlights 19th consecutive year of revenue growth, >80% customer satisfaction, Sterigenics expansion, Nelson Labs growth."],"consensus_eps_estimate":null,"consensus_eps_actual":0.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":1100441000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178689,"accession_number":"0001822479-25-000006","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2025-01-14T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Sotera Health expects FY2024 revenue ~$1.1B (+5% YoY), within prior guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Preliminary full-year 2024 revenue of approximately $1.1 billion.","Revenue growth of nearly 5% versus 2023, >5% on a constant currency basis.","Revenue range within guidance provided at Q3 2024 earnings release.","Full FY2024 results and 2025 outlook to be reported on February 27, 2025.","Chairman and CEO presented business update at J.P. Morgan Healthcare Conference."],"consensus_eps_estimate":null,"consensus_eps_actual":0.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":1100441000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178688,"accession_number":"0001822479-25-000003","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2025-01-06T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Sotera Health appoints Vincent K. Petrella as Lead Independent Director effective Jan 2, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Vincent K. Petrella, an independent director since 2020, appointed Lead Independent Director on January 2, 2025.","Petrella previously chaired the Audit Committee; will serve as liaison between Board, management, and shareholders.","CEO Michael B. Petras Jr. cited Petrella's experience and engagement as valuable to the Board.","Petrella expressed enthusiasm for the expanded role and commitment to driving shareholder value."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195348,"accession_number":"0001193125-24-262222","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2024-11-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Sotera Health outlines 2025-27 growth plan; warns of 2024 EBITDA risk from USD strength","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Targets organic revenue CAGR of 5-7% and adjusted EBITDA CAGR of 5-8% for 2025-2027.","Aims to expand adjusted EBITDA margins by at least 50 bps and generate cumulative FCF >$500M.","Sees serviceable addressable market of $18B; highlights strategic positioning and durable customer relationships.","Notes risk that 2024 Adjusted EBITDA could fall modestly below guidance due to recent USD strengthening."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195347,"accession_number":"0001822479-24-000046","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2024-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sotera Health Q3 net rev $285M (+8.5% YoY); net income $17M vs loss $14M; reaffirms FY outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net revenues $285M, up 8.5% YoY (8.9% constant currency); net income $17M ($0.06 diluted) vs net loss $14M in Q3 2023.","Adjusted EBITDA $146M, +9.0% YoY; Adjusted EPS $0.17, +$0.01 YoY.","Nine-month 2024 net revenues $810M (+9.6% YoY); net income $32M ($0.11 diluted) vs $13M prior year.","Reaffirming 2024 net revenue and Adjusted EBITDA outlook ranges.","CEO cites Nordion cobalt-60 timing benefit; investor day planned for Nov 20, 2024 in NYC."],"consensus_eps_estimate":null,"consensus_eps_actual":0.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":810238000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211608,"accession_number":"0001193125-24-215204","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2024-09-06T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Sotera Health insider selling: 25M shares sold at $15.03; director Donnini resigns","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Selling stockholders sold 25M shares at $15.03/share; company received no proceeds.","David Donnini, GTCR designee, resigned from Sotera Health board effective Sept 6, 2024, reducing board size to 11.","Resignation was not due to any disagreement with the company, management or board.","Underwriting agreement with Citigroup Global Markets Inc. filed as Exhibit 1.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211607,"accession_number":"0001822479-24-000038","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2024-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sotera Health Q2 net revenue up 8.3% to $277M; adj. EBITDA up 6.9% to $137M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $9M ($0.03 diluted) vs $24M ($0.08) in Q2 2023; decline due to debt refinancing charges.","Adjusted EPS $0.19 vs $0.20; higher interest expense weighed on earnings.","Refinanced debt structure, extending maturities to 2031; reaffirmed 2024 outlook.","First-half 2024 revenue $525M (+10.3%), adj. EBITDA $249M (+9.8%), adj. EPS $0.32.","All three segments (Sterigenics, Nordion, Nelson Labs) reported volume increases in Q2."],"consensus_eps_estimate":null,"consensus_eps_actual":0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":524770000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211606,"accession_number":"0001822479-24-000036","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Sotera Health appoints Christopher A. Simon to board of directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board increased from 11 to 12 directors; Simon appointed as Class III director effective August 1, 2024.","Simon is President & CEO of Haemonetics Corporation and will serve on the Leadership Development and Compensation Committee.","Simon is independent under Nasdaq Rule 5605(a)(2); no arrangement or reportable transactions with the company.","As non-employee director, Simon will receive standard cash retainer and annual restricted stock unit grant."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230324,"accession_number":"0001822479-24-000029","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2024-05-30T23:59:59+00:00","items":["1.01","1.02","2.03","3.03","7.01","8.01","9.01"],"status":"ready","headline":"Sotera Health closes $1.51B term loan and $750M notes, refinances existing debt, expects $5M interest savings in 2024","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Closed $1.509B Term Loan B (SOFR+3.25% or ABR+2.25%, 0% floor) and $750M 7.375% senior secured notes, both due 2031.","Proceeds from financings plus cash on hand used to refinance $1.76B and $496.3M existing term loans due 2026; prior credit agreement terminated.","2024 interest expense guidance reduced to $165M-$175M from prior range due to ~$5M annualized savings from lower rates.","Term loan amortizes at 1% per year ($15.1M annually) with balance due in 2031; notes may be redeemed at stated premiums starting June 2027.","Covenants limit dividends, additional debt, liens, investments, and asset sales; covenants suspend if notes achieve investment-grade rating."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230323,"accession_number":"0001822479-24-000027","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2024-05-24T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Sotera Health shareholders approve officer exculpation amendment, elect directors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Officer exculpation amendment approved with 86.4% of votes cast in favor.","All four Class I director nominees elected: Mihas, Neary, Petras, Wheadon.","Advisory say-on-pay proposal approved with 97.2% of votes cast in favor.","Ernst & Young ratified as auditor for fiscal 2024 with 99.9% of votes cast in favor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230322,"accession_number":"0001822479-24-000024","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2024-05-23T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Sotera Health subsidiary prices $750M 7.375% senior secured notes due 2031 to refinance term loans","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["SHH priced $750M aggregate principal of 7.375% senior secured notes due 2031.","Proceeds with new term loan and cash will refinance existing credit agreement term loans.","Closing expected May 30, 2024, subject to conditions and concurrent completion of new term loan.","Notes and guarantees secured on first-lien basis by substantially all assets of SHH and guarantors.","Notes offered privately under Rule 144A and Reg S; not registered under Securities Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230321,"accession_number":"0001822479-24-000022","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2024-05-16T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Sotera Health subsidiary plans to refinance existing term loans via new loan and secured debt","summary_kind":"llm","event_type":"debt","confidence":"medium","bullets":["Sotera Health Holdings intends to discuss refinancing its existing term loans with lenders.","Refinancing would combine a new term loan and other secured debt; terms are not final.","Existing term loans are under credit agreements from 2019 and 2023.","Completion subject to market conditions and other factors; no assurance given.","Specific size or terms of the refinancing were not disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230320,"accession_number":"0001822479-24-000015","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sotera Health Q1 net rev up 12.5% to $248M; Adj EBITDA up 13.7%; reaffirms 2024 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 net rev $248M (+12.5% YoY); net income $6M ($0.02 EPS) vs $3M ($0.01) YoY.","Adj EBITDA $112M (+13.7% YoY); Adj EPS $0.13 flat YoY.","Sterigenics segment net rev $166M (+4.1% YoY); segment income $86M (+3.6%).","Company reaffirms 2024 outlook amid market headwinds.","EPA finalized NESHAP update; Sterigenics expects to comply with emission control investments."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":248176000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230319,"accession_number":"0001822479-24-000017","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K/A","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sotera Health Q1 revenue up 12.5% to $248M; net income $6M; reaffirms 2024 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 net revenues $248M (+12.5% YoY); net income $6M ($0.02 diluted EPS) vs $3M ($0.01) in Q1 2023.","Adjusted EBITDA $112M (+13.7% YoY); Adjusted EPS $0.13 flat YoY.","Sterigenics segment net revenues $166M (+4.1%), segment income $86M (+3.6%).","Co reaffirms 2024 outlook; cites EPA finalizing updated NESHAP for ethylene oxide as manageable.","8-K/A filed to correct typo in prior exhibit; no impact on reported income metrics."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":248176000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248735,"accession_number":"0001193125-24-058025","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2024-03-04T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Sotera Health refinances revolver to 2029; selling shareholders sell 28.75M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amended credit agreement: new $83M revolver commitments, $37.5M additional LC commitments; total revolver unchanged at $423.75M.","Revolving facility maturity extended to March 1, 2029 (or 91 days before term loan maturity).","Selling stockholders sold 28,750,000 shares at $14.3075/share on March 4, 2024; company received no proceeds.","No other material changes to credit agreement covenants or terms.","Amendment No. 3 effective March 1, 2024; underwriting agreement dated February 28, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248734,"accession_number":"0001822479-24-000008","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2024-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sotera Health reports 2023 revenue $1.05B (+4.5%); net income $51M; 2024 outlook 4-6% growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["2023 net revenues $1.05B (+4.5% YoY); net income $51M vs loss of $234M in 2022.","Q4 net revenues $310M (+23.3% YoY); net income $39M vs loss of $320M (incl $408M legal reserve).","2023 Adjusted EBITDA $528M (+4.3%); Adjusted EPS $0.81, down $0.15 from 2022.","Sterigenics segment net revenues $667M (+6.5%); segment income $362M (+6.8%).","Full-year 2024 guidance: 4.0%-6.0% growth for Net Revenues and Adjusted EBITDA."],"consensus_eps_estimate":null,"consensus_eps_actual":0.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":1049288000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248733,"accession_number":"0001822479-24-000003","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2024-01-09T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Sotera Health expects FY2023 revenue $1.040-$1.050B, within prior guidance","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Preliminary full-year 2023 revenue guidance of $1.040-$1.050 billion, within previous range.","Q4 and full year results to be reported on February 27, 2024.","CEO cites top-line growth in a challenging environment."],"consensus_eps_estimate":null,"consensus_eps_actual":0.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":1049288000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266223,"accession_number":"0001822479-23-000075","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2023-12-21T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Sotera Health subsidiaries settle 79 EO claims for $35M; payments expected Jan 2024","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Settling defendants pay $35M to resolve 79 ethylene oxide exposure claims from Sterigenics' Atlanta operations.","100% of claimants consented; one plaintiff dismisses with prejudice, 78 executed settlement agreements.","Payment due by Jan 5, 2024 or five business days after qualified settlement fund is created.","Settling defendants deny any liability; settlement does not constitute admission of wrongdoing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266222,"accession_number":"0001822479-23-000065","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2023-11-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Sotera Health appoints Karen A. Flynn as new director, board expanded to 11","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board increased from 10 to 11 members; Karen A. Flynn appointed effective Nov 13, 2023.","Flynn most recently served as Interim President of BioModalities at Catalent Pharma Solutions.","She is deemed independent under Nasdaq rules and will serve as Class II director until 2025 annual meeting.","She will receive standard non-employee director compensation (annual cash retainer + RSU grant).","No arrangements or transactions requiring disclosure; enters customary indemnification agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266221,"accession_number":"0001822479-23-000059","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2023-11-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sotera Health Q3 net loss of $14M; rev +6%, adj EBITDA +7%, legal settlement hit","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net loss $14M ($0.05 diluted) vs net income $25M ($0.09) a year ago; includes $35M legal settlement charge.","Net revenues rose 5.8% to $263M from $249M in Q3 2022.","Adjusted EBITDA up 7.3% to $134M; Adjusted EPS fell to $0.21 from $0.23 on higher interest expense.","Company reaffirms full-year 2023 outlook but anticipates results at the lower end of the range."],"consensus_eps_estimate":null,"consensus_eps_actual":0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":739049000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266220,"accession_number":"0001822479-23-000054","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2023-10-16T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Sotera Health settles 79 Georgia EO claims for $35M; trial stayed pending","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Subsidiaries Sotera Health LLC and Sterigenics U.S. LLC enter binding term sheet to settle 79 EO exposure claims.","Settlement payment of $35 million; claims dismissed with prejudice after conditions met.","Conditions include 100% plaintiff consent and stay of trial scheduled for Oct 23, 2023.","Settlement expected to conclude in 45–60 days; company denies any liability or wrongdoing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283471,"accession_number":"0001822479-23-000049","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2023-08-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sotera Health Q2 net revenue $255M (-4% YoY), net income $24M; cuts full-year outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net revenues $255M, down 4% YoY; net income $24M ($0.08 diluted EPS) vs $30M ($0.11) in Q2 2022.","Adjusted EBITDA $128M, down 6% YoY; Adjusted EPS $0.21 vs $0.27 in prior year.","Full-year 2023 guidance revised: net revenue $1.035B-$1.055B, Adjusted EBITDA $520M-$535M.","Decline driven by expected Nordion Cobalt-60 harvest schedule timing.","Total debt $2.3B, net leverage ratio 4.2x as of June 30, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":475872000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283470,"accession_number":"0001822479-23-000044","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2023-07-07T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Sotera Health releases $408M settlement funds for ethylene oxide claims; claims dismissed","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["On June 30, 2023, ~$408M settlement funds were released from escrow for January 2023 settlements.","879 eligible claimants opted in; their claims against Sterigenics and Sotera Health LLC were dismissed with prejudice on July 6.","An immaterial fraction remains in escrow for three non-opting claimants; funds revert to Sterigenics if not opted in by Dec 31, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302950,"accession_number":"0001822479-23-000042","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2023-06-26T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Sotera Health appoints Jonathan M. Lyons as CFO, effective June 26, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lyons succeeds Interim CFO Michael Biehl, will lead finance and accounting.","Annual base salary $475,000; target bonus 70% of base, prorated.","Long-term equity target $1.2M (RSUs and options, 3-year vest).","Sign-on cash $200,000 and sign-on RSUs $1.0M, both with 3-year vest.","Lyons previously VP Corporate FP&A at Owens Corning, also held roles at Cardinal Health."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302949,"accession_number":"0001822479-23-000039","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2023-06-22T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"Sotera Health completes opt-in for $408M EO settlement; 99.7% of eligible claimants join","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["879 of 882 eligible claimants opted into the January 2023 ethylene oxide settlement.","Sterigenics waived walkaway rights and will proceed with 879 settling claimants.","Three opt-out claimants will proceed to pretrial discovery per Circuit Court schedule.","Court entered good-faith settlement order; funds disbursed ten days after order.","Company will incur no additional charges beyond those recognized in Q4 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302948,"accession_number":"0001822479-23-000037","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2023-06-01T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Sotera Health shareholders elect three Class III directors, approve say-on-pay and auditor ratification","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All three director nominees elected: Sean Cunningham, Robert Knauss, Vincent Petrella each received majority votes.","Advisory say-on-pay resolution approved with 229,154,947 For vs 38,382,040 Against, plus abstentions.","Ratification of Ernst & Young as auditor for FY2023 approved overwhelmingly: 269,320,023 For, 504,464 Against.","Over 95% of outstanding shares voted, constituting quorum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302947,"accession_number":"0001822479-23-000030","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2023-05-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sotera Health Q1 2023 revenue falls 7% to $221M; net income drops to $3M; reaffirms 2023 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues $221M, down 6.8% YoY; constant currency down 5.3%, driven by Nordion Cobalt-60 harvest timing.","Net income $3M ($0.01 diluted EPS) vs $31M ($0.11) in Q1 2022; Adjusted EPS $0.13 vs $0.22.","Adjusted EBITDA $98M, down 14.6% from $115M; total debt $2.3B, net leverage 3.4x.","Company reaffirms 2023 outlook despite Q1 declines attributed to expected Nordion harvest schedule timing."],"consensus_eps_estimate":null,"consensus_eps_actual":0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":220590000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322586,"accession_number":"0001822479-23-000026","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2023-03-29T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Sotera Health enters $408M settlement agreements for EO claims at Willowbrook facility","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Definitive Master Settlement Agreements signed with Plaintiffs' Executive Committee representing over 870 claimants.","Settlement payments of $408 million to be funded into escrow on May 1, 2023.","Settlement process targeted for completion by August 2023, subject to opt-in consents.","Scope and terms consistent with binding term sheets disclosed in January 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322585,"accession_number":"0001193125-23-075979","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2023-03-22T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"Sotera Health upsizes revolver by $76.3M to $423.8M, switches from LIBOR to SOFR","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Revolving credit facility increased from $347.5M to $423.8M via incremental commitments.","Letter of credit commitments raised from ~$196M to $361M.","Interest rate on USD draws: Term SOFR/Daily SOFR + 2.75% or base rate + 1.75%.","No outstanding balance; proceeds for general corporate purposes.","Maturity remains June 13, 2026; no changes to covenants or other terms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322584,"accession_number":"0001822479-23-000012","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2023-02-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sotera Health Q4 net loss $320M on $408M legal reserve; provides 2023 outlook of 5-9% growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenues $252M (+4% YoY); net loss $320M ($1.14/share) vs net income $36M in Q4 2021.","Q4 net loss includes $408M reserve for ethylene oxide claims settlement in Cook County, IL.","Q4 adjusted EBITDA $130M (+4% YoY); adjusted EPS $0.25 (+$0.02).","Closed $500M Term Loan B in February 2023.","Full-year 2023 outlook: net revenues and adjusted EBITDA growth of 5% to 9%."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.83,"consensus_revenue_estimate":null,"consensus_revenue_actual":1003687000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322583,"accession_number":"0001193125-23-046817","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2023-02-23T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"Sotera Health closes $500M Term Loan B, upsized from $425M, to fund $408M ethylene oxide litigation settlement","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Sotera Health closed $500M Term Loan B, upsized from previously announced $425M.","Proceeds to fund $408M ethylene oxide litigation settlement in Cook County, IL, pay down revolver, enhance liquidity.","Loan bears SOFR+3.75% (50bps floor) or base+2.75%, matures Dec 2026, amortizes 1% annually.","Soft call premium of 1% for certain repricing transactions within first six months after closing.","Covenants substantially same as existing credit agreement; obligations secured on first-priority basis."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322582,"accession_number":"0001193125-23-034187","cik":1822479,"company_name":"Sotera Health Co","ticker":"SHC","form_type":"8-K","filed_at":"2023-02-13T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Sotera Health reaffirms 2022 guidance, plans $425M Term Loan B to fund $408M EO litigation settlement","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Reaffirms 2022 net revenue guidance of $995M-$1.005B and Adjusted EBITDA of $500M-$510M.","Expects 2022 net loss of $226M-$236M including a $408M legal reserve for ethylene oxide settlement.","Plans $425M Term Loan B facility to fund $408M EO settlement, pay down revolver, and boost liquidity.","Preliminary estimates subject to completion of year-end closing; final results expected February 28, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":4518470980.409266,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2023-02-13T23:59:59+00:00|322582"}